• 853 Citations
  • 9 h-Index
19992020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 853 Citations
  • 9 h-Index
  • 20 Article
  • 3 Letter
  • 3 Review article
Filter
Article
2020

A phenylphthalimide derivative, TC11, induces apoptosis by degrading MCL1 in multiple myeloma cells

Ichikawa, D., Nakamura, M., Murota, W., Osawa, S., Matsushita, M., Yanagawa, H. & Hattori, Y., 2020 Jan 1, In : Biochemical and Biophysical Research Communications. 521, 1, p. 252-258 7 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)
2018

A novel derivative (GTN024) from a natural product, komaroviquinone, induced the apoptosis of high-risk myeloma cells via reactive oxygen production and ER stress

Okayama, M., Kitabatake, S., Sato, M., Fujimori, K., Ichikawa, D., Matsushita, M., Suto, Y., Iwasaki, G., Yamada, T., Kiuchi, F., Hirao, M., Kunieda, H., Osada, M., Okamoto, S. & Hattori, Y., 2018 Nov 2, In : Biochemical and Biophysical Research Communications. 505, 3, p. 787-793 7 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Anticancer Drug Prescription Patterns in Japan: Future Directions in Cancer Therapy

Shibata, S., Matsushita, M., Saito, Y. & Suzuki, T., 2018 Nov 1, In : Therapeutic Innovation and Regulatory Science. 52, 6, p. 718-723 6 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)
2017

An empirical study of the prescription pattern of drugs for hematological malignancies in Japan from 2010-2014

Shibata, S., Wayama, Y., Tsuyuki, A., Matsushita, M., Chiba, K., Matsuki, E., Okamoto, S. & Suzuki, T., 2017, In : Biological and Pharmaceutical Bulletin. 40, 6, p. 894-901 8 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)

A novel phenylphthalimide derivative, pegylated TC11, improves pharmacokinetic properties and induces apoptosis of high-risk myeloma cells via G2/M cell-cycle arrest

Aida, S., Hozumi, M., Ichikawa, D., Iida, K., Yonemura, Y., Tabata, N., Yamada, T., Matsushita, M., Sugai, T., Yanagawa, H. & Hattori, Y., 2017, (Accepted/In press) In : Biochemical and Biophysical Research Communications.

Research output: Contribution to journalArticle

1 Citation (Scopus)

CXorf48 is a potential therapeutic target for achieving treatment-free remission in CML patients

Matsushita, M., Ozawa, K., Suzuki, T., Nakamura, M., Nakano, N., Kanchi, S., Ichikawa, D., Matsuki, E., Sakurai, M., Karigane, D., Kasahara, H., Tsukamoto, N., Shimizu, T., Mori, T., Nakajima, H., Okamoto, S., Kawakami, Y. & Hattori, Y., 2017 Sep 1, In : Blood cancer journal. 7, 9, e601.

Research output: Contribution to journalArticle

3 Citations (Scopus)
1 Citation (Scopus)
2 Citations (Scopus)
2016

Identification of novel HLA-A∗24:02-restricted epitope derived from a homeobox protein expressed in hematological malignancies

Matsushita, M., Otsuka, Y., Tsutsumida, N., Tanaka, C., Uchiumi, A., Ozawa, K., Suzuki, T., Ichikawa, D., Aburatani, H., Okamoto, S., Kawakami, Y. & Hattori, Y., 2016 Jan 1, In : PloS one. 11, 1, e0146371.

Research output: Contribution to journalArticle

3 Citations (Scopus)
2015

A novel phthalimide derivative, TC11, has preclinical effects on high-risk myeloma cells and osteoclasts

Matsushita, M., Ozaki, Y., Hasegawa, Y., Terada, F., Tabata, N., Shiheido, H., Yanagawa, H., Oikawa, T., Matsuo, K., Du, W., Yamada, T., Hozumi, M., Ichikawa, D. & Hattori, Y., 2015 Jan 24, In : PloS one. 10, 1, e0116135.

Research output: Contribution to journalArticle

6 Citations (Scopus)
2010

Chimeric antigen receptors combining 4-1BB and CD28 signaling domains augment PI 3 kinase/AKT/Bcl-X L activation and CD8 T cell-mediated tumor eradication

Zhong, X. S., Matsushita, M., Plotkin, J., Riviere, I. & Sadelain, M., 2010 Feb, In : Molecular Therapy. 18, 2, p. 413-420 8 p.

Research output: Contribution to journalArticle

265 Citations (Scopus)
2007

Genetically targeted T cells eradicate systemic acute lymphoblastic leukemia xenografts

Brentjens, R. J., Santos, E., Nikhamin, Y., Yeh, R., Matsushita, M., La Perle, K., Quintás-Cardama, A., Larson, S. M. & Sadelain, M., 2007 Sep 15, In : Clinical Cancer Research. 13, 18, p. 5426-5435 10 p.

Research output: Contribution to journalArticle

275 Citations (Scopus)
2006

Possible involvement of allogeneic antigens recognised by donor-derived CD4 + cytotoxic T cells in selective GVL effects after stem cell transplantation of patients with haematological malignancy

Matsushita, M., Yamazaki, R., Ikeda, H., Mori, T., Sumimoto, H., Fujita, T., Okamoto, S., Ikeda, Y. & Kawakami, Y., 2006 Jan 1, In : British Journal of Haematology. 132, 1, p. 56-65 10 p.

Research output: Contribution to journalArticle

11 Citations (Scopus)
2004

Identification of bladder cancer antigens recognized by IgG antibodies of a patient with metastatic bladder cancer

Ito, K., Fujita, T., Akada, M., Kiniwa, Y., Tsukamoto, M., Yamamoto, A., Matsuzaki, Y., Matsushita, M., Asano, T., Nakashima, J., Tachibana, M., Hayakawa, M., Ikeda, H., Murai, M. & Kawakami, Y., 2004 Feb 20, In : International Journal of Cancer. 108, 5, p. 712-724 13 p.

Research output: Contribution to journalArticle

13 Citations (Scopus)

Quantitative analysis of PRAME for detection of minimal residual disease in leukemia.

Matsushita, M., Yamazaki, R. & Kawakami, Y., 2004, In : Methods in molecular medicine. 97, p. 267-275 9 p.

Research output: Contribution to journalArticle

7 Citations (Scopus)
2003

Genetic reversion in an acute myelogenous leukemia cell line from a Fanconi anemia patient with biallelic mutations in BRCA2

Ikeda, H., Matsushita, M., Waisfisz, Q., Kinoshita, A., Oostra, A. B., Nieuwint, A. W. M., De Winter, J. P., Hoatlin, M. E., Kawai, Y., Sasaki, M. S., D'Andrea, A. D., Kawakami, Y. & Joenje, H., 2003 May 15, In : Cancer Research. 63, 10, p. 2688-2694 7 p.

Research output: Contribution to journalArticle

45 Citations (Scopus)
2002

Development of immunotherapy using allogeneic antigens for hematological malignancy

Matsushita, M., Yamazaki, R., Fujita, T. & Kawakami, H., 2002 Feb, In : [Rinshō ketsueki] The Japanese journal of clinical hematology. 43, 2, p. 94-96 3 p.

Research output: Contribution to journalArticle

2001

Quantitative monitoring of the PRAME gene for the detection of minimal residual disease in leukaemia

Matsushita, M., Ikeda, H., Kizaki, M., Okamoto, S., Ogasawara, M., Ikeda, Y. & Kawakami, Y., 2001, In : British Journal of Haematology. 112, 4, p. 916-926 11 p.

Research output: Contribution to journalArticle

68 Citations (Scopus)
1999

1,25-Dihydroxyvitamin D3 induces differentiation of a retinoic acid- resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21(WAF1/CIP1) and p27(KIP1)

Muto, A., Kizaki, M., Yamato, K., Kawai, Y., Kamata-Matsushita, M., Ueno, H., Ohguchi, M., Nishihara, T., Koeffler, H. P. & Ikeda, Y., 1999 Apr 1, In : Blood. 93, 7, p. 2225-2233 9 p.

Research output: Contribution to journalArticle

86 Citations (Scopus)

PRAME protein expressed in leukemia cells as a target molecule for immunotherapy

Ikeda, H., Matsushita, M. & Kawakami, H., 1999 Jun, In : [Rinshō ketsueki] The Japanese journal of clinical hematology. 40, 6, p. 484-486 3 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)